0001567619-21-011654.txt : 20210603 0001567619-21-011654.hdr.sgml : 20210603 20210603183412 ACCESSION NUMBER: 0001567619-21-011654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210527 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rousseau Raphael CENTRAL INDEX KEY: 0001754287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 21994078 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone bio, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Gritstone Oncology, Inc. DATE OF NAME CHANGE: 20151023 4 1 doc1.xml FORM 4 X0306 4 2021-05-27 0 0001656634 Gritstone bio, Inc. GRTS 0001754287 Rousseau Raphael C/O GRITSTONE ONCOLOGY, INC. 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 0 1 0 0 See Remarks Common Stock 2021-05-27 4 M 0 2900 0.759 A 2900 D Common Stock 2021-05-27 4 S 0 2900 9.0040 D 0 D Stock Option (Right to Buy) 0.759 2021-05-27 4 M 0 2900 0 D 2027-05-17 Common Stock 2900 122426 D Fully exercisable. Executive Vice President and Chief Medical Officer /s/ Rahsaan Thompson, Attorney-in-Fact for Raphael Rousseau 2021-06-03